Neuroscience Research Australia

Last updated

Neuroscience Research Australia
(1)Neuroscience Research Australia-5.jpg
Established1991 (1991)
Research typeMedical research
Director Professor Matthew Kiernan AM [1]
Faculty 400+
Location Sydney, New South Wales
Campus Randwick
NicknameNeuRA
Affiliations University of New South Wales, Black Dog Institute, South Eastern Sydney Local Health District (SESLHD), Mindgardens Network.
Website www.neura.edu.au

Neuroscience Research Australia (or NeuRA) is an independent, not for profit medical research institute based in Sydney, Australia.

Contents

Neuroscience Research Australia is made up of over 400 researchers specialising in research aimed at improving the lives of people living with brain and nervous system disorders. The institute’s research spans neurodegeneration, including dementia and Parkinson’s disease; mental health and mental illness including bipolar disorder and schizophrenia; and translational neuroscience including falls prevention, pain and injury prevention.

NeuRA regularly receives funding for projects from the National Health and Medical Research Council, Australian Research Council and Medical Research Future Fund, as well as private philanthropy.

Situated among the Randwick Health Precinct, NeuRA is affiliated with Black Dog Institute, South Eastern Sydney Local Health District (SESLHD), UNSW Sydney and Mindgardens Network.

Research activity

NeuRA’s research activity is organised into three themes:

NeuRA houses research centres, including the Sydney Brain Bank, [2] Spinal Cord Injury Research Centre, [3] Transurban Road Safety Centre [4] and Centre for Pain IMPACT. [5]

NeuRA runs the Australian and New Zealand Hip Fracture Registry which works to improve care outcomes. It was established by the Professor Jacqui Close and Professor Ian Harris in 2012.

History

Early Years

NeuRA was previously called the Prince of Wales Medical Research Institute and was established in 1991 by Professor Ian McCloskey, Professor David Burke, Professor Simon Gandevia and Professor Erica Potter with the support of the Eastern Sydney Area Health Service (now South Eastern Sydney and Illawarra Area Health Service) and the University of New South Wales. In 1993 the Institute was established as an independent, not-for-profit company [6] and researchers moved into buildings on the site of the old Randwick Chest Hospital, next to the Prince of Wales Hospital in Randwick. It was officially opened on 8 November 1993 by the Commonwealth Minister for Health Graham Richardson and the NSW Minister for Health Ron Phillips.[ citation needed ]

On 15 November 2000, the Premier of New South Wales, Bob Carr, officially opened the new sections of the institute. In June 2009 the Minister for Science and Medical Research Jodi McKay opened the Prince Henry Wing extension.[ citation needed ]

New building and renaming

In May 2007, the NSW government gave planning approval to the concept and project plans for a Neuroscience Research Precinct to be built on the existing site. [7] Building works began on the first phase of the project in March 2010; with the first stage of 13,000 square metres (140,000 sq ft) designed by COX Architecture completed in 2013 at a cost of A$40 million. [8] The completed building provides six stories of laboratory and clinical research space, 25,000 square metres (270,000 sq ft) of floor space and the ability to house up to 700 researchers.[ citation needed ] The institute relaunched as Neuroscience Research Australia (NeuRA) on 1 June 2010. [9]

In 2018, NeuRA formed a cooperative partnership of four clinical, educational and research allies, including Black Dog Institute, South Eastern Sydney Local Health District (SESLHD) and UNSW Sydney to create Mindgardens Neuroscience Network which became the largest collaboration between researchers and clinicians in the Southern Hemisphere on brain disorders. [10]

Research Achievements

Professor Peter Schofield AO and Dr Bill Brooks are founding members of the Dominantly Inherited Alzheimer Network (DIAN) study – a significant collaborative effort studying familial Alzheimer’s disease through sites in the US, Australia, England and Germany. In 2012, DIAN researchers showed the onset of symptoms in Alzheimer’s disease is preceded by the accumulation of amyloid (abnormal protein) in the brain over a period of 15 to 20 years. This study paved the way for using biomarkers as surrogate end points in clinical trials. [11]

In 2013, National Child Restraint Guidelines developed by Professor Lynne Bilston and Associate Professor Julie Brown were adopted by the Australian government and this resulted in a reduction of child fatalities in motor vehicles by 45% . [12]

In 2017, Associate Professor Ingvars Birznieks discovered the neural code used to signal touch sensation. [13]

In November 2018, NeuRA’s team of neuroscientists led by George Paxinos reported a finding of a new region of the human brain which they called the endorestiform nucleus. The group adopted an innovative enhanced staining method. [14]

In 2018, Professor Cyndi Shannon Weickert discovers immune cells in brains of many people with schizophrenia opening new avenues for treatment. [15]

In 2019, Professor Kaarin Anstey and Associate Professor Ruth Peters contribute to World Health Organisation guidelines on risk reduction of cognitive decline and dementia. [16] The Guidelines provide evidence-based recommendations on relevant lifestyle behaviours and interventions. They are designed to be a vital tool for health care providers, governments and policy makers.

In 2021, Associate Professors Jan Fullerton and Tom Weickert and Professors Peter Schofield AO, Melissa Green and Professor Cyndi Shannon Weickert were recently involved in the world’s largest bipolar genetics study, comprising 200 institutions and over 415,000 research participants. The study identified 64 genomic regions that make people more susceptible to bipolar disorder – more than doubling the number of regions previously identified – and pinpointed the specific genes and pathways impacted. The study also revealed DNA sequence differences in specific genes that are involved in the therapeutic action of antipsychotics and a range of other medicines, which could lead to the development of more targeted medications, or the repurposing of existing medications as potential treatments. [17]

See also

Related Research Articles

<span class="mw-page-title-main">Institute of Psychiatry, Psychology and Neuroscience</span> Research institution in London, England

The Institute of Psychiatry, Psychology & Neuroscience (IoPPN) is a leading centre for mental health and neuroscience research, education and training in Europe. It is dedicated to understanding, preventing and treating mental illness, neurological conditions, and other conditions that affect the brain. The IoPPN is a faculty of King's College London, England, and was previously known as the Institute of Psychiatry (IoP).

<span class="mw-page-title-main">Florey Institute of Neuroscience and Mental Health</span> Australian medical research institute

The Florey Institute of Neuroscience and Mental Health, more commonly known as The Florey, is an Australian medical research institute that undertakes research into treatments for brain and mind disorders. The institute's areas of interest include Parkinson's disease, stroke, motor neurone disease, addiction, epilepsy, multiple sclerosis, Autism, Huntington's disease, depression, schizophrenia, brain function in health and disease, heart failure, and dementia.

<span class="mw-page-title-main">Organic brain syndrome</span> Disorder of mental function whose cause is alleged to be known as physiological

Organic brain syndrome, also known as organic brain disease, organic brain damage, organic brain disorder, organic mental syndrome, or organic mental disorder, refers to any syndrome or disorder of mental function whose cause is alleged to be known as organic (physiologic) rather than purely of the mind. These names are older and nearly obsolete general terms from psychiatry, referring to many physical disorders that cause impaired mental function. They are meant to exclude psychiatric disorders. Originally, the term was created to distinguish physical causes of mental impairment from psychiatric disorders, but during the era when this distinction was drawn, not enough was known about brain science for this cause-based classification to be more than educated guesswork labeled with misplaced certainty, which is why it has been deemphasized in current medicine. While mental or behavioural abnormalities related to the dysfunction can be permanent, treating the disease early may prevent permanent damage in addition to fully restoring mental functions. An organic cause to brain dysfunction is suspected when there is no indication of a clearly defined psychiatric or "inorganic" cause, such as a mood disorder.

The Mental Health Research Institute (MHRI) is a former Australian medical research institute that was focused upon improving the diagnosis, treatment and prevention of major mental disorders. The MHRI was active between 1956 and 2012, when it was merged with the Florey Neuroscience Institutes to form the Florey Institute of Neuroscience and Mental Health. Based in Melbourne, Victoria, the research efforts of the MHRI were focused on understanding schizophrenia, bipolar and major mood disorders, and Alzheimer's disease.

John Quinn Trojanowski was an American academic research neuroscientist specializing in neurodegeneration. He and his partner, Virginia Man-Yee Lee, MBA, Ph.D., are noted for identifying the roles of three proteins in neurodegenerative diseases: tau in Alzheimer's disease, alpha-synuclein in Parkinson's disease, and TDP-43 in Amyotrophic Lateral Sclerosis (ALS) and frontotemporal degeneration.

<span class="mw-page-title-main">Black Dog Institute</span>

The Black Dog Institute is a not-for-profit facility for diagnosis, treatment and prevention of mood disorders such as depression, anxiety and bipolar disorder. It was founded in 2002 by the UNSW School of Psychiatry Scientia Professor Gordon Parker and is based in Sydney, Australia.

Samuel E. Gandy, is a neurologist, cell biologist, Alzheimer's disease (AD) researcher and expert in the metabolism of the sticky substance called amyloid that clogs the brain in patients with Alzheimer's. His team discovered the first drugs that could lower the formation of amyloid.

The Semel Institute for Neuroscience and Human Behavior is a research institute of the University of California Los Angeles (UCLA). It includes a number of centers, including the "Center for Neurobehavioral Genetics", which uses DNA sequencing, gene expression studies, bioinformatics, and the genetic manipulation of model organisms to understand brain and behavioral phenotypes.

Clinical neuroscience is a branch of neuroscience that focuses on the scientific study of fundamental mechanisms that underlie diseases and disorders of the brain and central nervous system. It seeks to develop new ways of conceptualizing and diagnosing such disorders and ultimately of developing novel treatments.

Perminder Sachdev is an Indian neuropsychiatrist based in Australia. He is a professor of neuropsychiatry at the University of New South Wales (UNSW), co-director of the UNSW Centre for Healthy Brain Aging, and clinical director of the Neuropsychiatric Institute at the Prince of Wales Hospital, Sydney. He is considered a trailblazer in the field of neuropsychiatry. Sachdev's research interests include ageing, vascular cognitive disorders such as vascular dementia, and psychiatric disorders.

<span class="mw-page-title-main">George Paxinos</span> Greek Australian neuroscientist

George Paxinos AO DSc FASSA FAA FRSN FAHMS is a Greek Australian neuroscientist, born in Ithaca, Greece. He completed his BA in psychology at the University of California at Berkeley and his PhD at McGill University in Montreal, Canada. After a postdoctoral year at Yale University, he moved to the School of Psychology of the University of New South Wales in Sydney, Australia. He is currently an NHMRC Senior Principal Research Fellow at Neuroscience Research Australia and Scientia Professor of Medical Sciences at the University of New South Wales.

<span class="mw-page-title-main">Krembil Research Institute</span> Academic medical research institute in Toronto

The Krembil Research Institute, formerly known as the Toronto Western Research Institute, is an academic medical research institute in Toronto. It is one of the largest research institutes in Canada focusing on human neurological disease.

<span class="mw-page-title-main">Richard Bryant (psychologist)</span> Australian psychologist

Richard Allan Bryant is an Australian medical scientist. He is Scientia Professor of Psychology at the University of New South Wales (UNSW) and director of the UNSW Traumatic Stress Clinic, based at UNSW and Westmead Institute for Medical Research. His main areas of research are posttraumatic stress disorder (PTSD) and prolonged grief disorder. On 13 June 2016 he was appointed a Companion of the Order of Australia (AC), for eminent service to medical research in the field of psychotraumatology, as a psychologist and author, to the study of Indigenous mental health, as an advisor to a range of government and international organisations, and to professional societies.

Kaarin Anstey is an Australian Laureate Fellow and one of Australia's top dementia scientists. She is Co-Deputy Director of the ARC Centre of Excellence in Population Ageing Research (CEPAR) at the University of New South Wales, Australia, where she is Scientia Professor of Psychology. Kaarin Anstey is an Honorary Professor at the Australian National University and a Fellow of the Academy of the Social Sciences in Australia. She is a Director of the NHMRC Dementia Centre for Research Collaboration, Senior Principal Research Scientist at NeuRA and leads the NHMRC Centre of Research Excellence in Cognitive Health and the UNSW Ageing Futures Institute.

<span class="mw-page-title-main">Natalie Matosin</span> Australian scientist researching stress

Dr. Natalie Matosin is an Australian scientist known for research into the impacts of the human brain in health and disease, and particularly stress and its role in mental illness. Matosin's research has been published in prestigious academic journals, as well as on The Conversation. Matosin spoke at TEDx Hamburg in June 2017 and is the 2021 Al & Val Rosenstrauss Fellow. She was previously a National Health and Medical Research Council CJ Martin Early Career Research Fellow, and Alexander von Humboldt Fellow. In 2017, Matosin was listed as a Forbes 30 Under 30 in Europe in the category of Science & Healthcare, placing her in the top 1% of innovators worldwide.

Bettina Meiser is a professor at the University of New South Wales, with expertise in the psychosocial aspects of genetics; cancer, hereditary cancer, and the impact of genetic counselling and testing.

Simon Gandevia is from Melbourne, Australia. He studied at the University of New South Wales where he received three research doctorates: PhD, MD, and DSc. Gandevia's current research focuses primarily on the relationship between the human brain and movement. His work contributes to various sub-fields within medicine particularly focusing on pathological mechanisms, such as neurology, cardiorespiratory medicine and rehabilitation. In addition, he worked with many editorial boards such as the Journal of Physiology. Gandevia had supervised and trained several doctoral students. Gandevia also writes about research ethics and quality of experimental procedures in order to facilitate the development of concepts about ethics in human experimental studies. In 1998, Gandevia was elected a Fellow of the Australian Academy of Science, and the Australian Academy of Health and Medical Science in 2016.

Joseph Thomas Coyle Jr. is an American psychiatrist and neuroscientist. He is the Eben S. Draper Professor of Psychiatry and Neuroscience at Harvard Medical School.

Glenda Margaret Halliday is an Australian neuroscientist. As of 2021, she is a professor at the University of Sydney and research fellow in the National Health and Medical Research Council (NHMRC). She was named 2022 NSW Scientist of the Year.

References

  1. Kates, Beatrix. "Professor Matthew Kiernan AM as NeuRA Chief Executive Officer". UNSW. UNSW Sydney.
  2. see https://www.neura.edu.au/scientific-facility/sydneybrainbank/
  3. see https://neura.edu.au/research/research-expertise/spinal-cord-injury
  4. "Transurban Road Safety Centre | Neuroscience Research Australia".
  5. see https://neura.edu.au/research/research-expertise/centre-for-pain-impact
  6. "Prince of Wales Medical Research Institute". Wayback Machine. NSW Office for Science and Medical Research. Archived from the original on 13 June 2009.
  7. "$30 million for Neuroscience research". 9 May 2007.
  8. "Neuroscience Research Australia (NeuRA) Randwick, Sydney". Cox Architecture.
  9. "Neuroscience Research Australia launches new identity" . Retrieved 31 May 2010.
  10. "Brain disorders cost Australians $74 billion per annum". hospitalhealth.com.au. Retrieved 20 July 2019.
  11. "30 years Connecting research to results" (PDF). www.neura.edu.au.
  12. "30 years Connecting research to results" (PDF). www.neura.edu.au.
  13. How do you feel what you can't touch? Scientists crack the code in Sydney Morning Herald https://www.smh.com.au/national/how-do-you-feel-what-you-can-t-touch-scientists-crack-the-nerve-code-20181211-p50lmu.html
  14. "Scientists Report Discovery of New Region of the Human Brain". interestingengineering.com. 23 November 2018. Retrieved 20 July 2019.
  15. Smith, Bel (14 February 2020). "Discovery of immune cells in the brain creates new possibilities for schizophrenia treatment". Medical Research NSW Government.
  16. "New WHO Guidelines recommend specific interventions for reducing the risk of dementia".
  17. "Study identifies genetic signatures associated with bipolar disorder". UNSW Newsroom.